Piperacillin/Tazobactam in critically ill morbidly obese patients: A case series: The first One‐Centre experience with TDM

Abstract The aim of this article is to demonstrate extreme interindividual variability of piperacilin/tazobactam (PIP/TAZO) pharmacokinetics in critically ill morbidly obese patients and to emphasize the need for the practice of routine PIP/TAZO plasma concentrations measurement in order to ensure o...

Full description

Bibliographic Details
Main Authors: M. Mieresova, K. Balazova, J. Kubele, D. Cerny, M. Halacova
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.7032
_version_ 1827976461211926528
author M. Mieresova
K. Balazova
J. Kubele
D. Cerny
M. Halacova
author_facet M. Mieresova
K. Balazova
J. Kubele
D. Cerny
M. Halacova
author_sort M. Mieresova
collection DOAJ
description Abstract The aim of this article is to demonstrate extreme interindividual variability of piperacilin/tazobactam (PIP/TAZO) pharmacokinetics in critically ill morbidly obese patients and to emphasize the need for the practice of routine PIP/TAZO plasma concentrations measurement in order to ensure optimal efficacy and safety of antibiotic therapy.
first_indexed 2024-04-09T20:35:49Z
format Article
id doaj.art-895e9ea7aa6d4f1abcd12a404ab73904
institution Directory Open Access Journal
issn 2050-0904
language English
last_indexed 2024-04-09T20:35:49Z
publishDate 2023-03-01
publisher Wiley
record_format Article
series Clinical Case Reports
spelling doaj.art-895e9ea7aa6d4f1abcd12a404ab739042023-03-30T10:21:24ZengWileyClinical Case Reports2050-09042023-03-01113n/an/a10.1002/ccr3.7032Piperacillin/Tazobactam in critically ill morbidly obese patients: A case series: The first One‐Centre experience with TDMM. Mieresova0K. Balazova1J. Kubele2D. Cerny3M. Halacova4Department of Clinical Pharmacy Na Homolce Hospital Prague Czech RepublicDepartment of Clinical Pharmacy Na Homolce Hospital Prague Czech RepublicDepartment of Clinical Microbiology and Antibiotic Surveillance Na Homolce Hospital Prague Czech RepublicDepartment of Clinical Pharmacy Na Homolce Hospital Prague Czech RepublicDepartment of Clinical Pharmacy Na Homolce Hospital Prague Czech RepublicAbstract The aim of this article is to demonstrate extreme interindividual variability of piperacilin/tazobactam (PIP/TAZO) pharmacokinetics in critically ill morbidly obese patients and to emphasize the need for the practice of routine PIP/TAZO plasma concentrations measurement in order to ensure optimal efficacy and safety of antibiotic therapy.https://doi.org/10.1002/ccr3.7032critical illnessmorbid obesitypiperacillin/tazobactam (PIP/TAZO)therapeutic drug monitoring (TDM)
spellingShingle M. Mieresova
K. Balazova
J. Kubele
D. Cerny
M. Halacova
Piperacillin/Tazobactam in critically ill morbidly obese patients: A case series: The first One‐Centre experience with TDM
Clinical Case Reports
critical illness
morbid obesity
piperacillin/tazobactam (PIP/TAZO)
therapeutic drug monitoring (TDM)
title Piperacillin/Tazobactam in critically ill morbidly obese patients: A case series: The first One‐Centre experience with TDM
title_full Piperacillin/Tazobactam in critically ill morbidly obese patients: A case series: The first One‐Centre experience with TDM
title_fullStr Piperacillin/Tazobactam in critically ill morbidly obese patients: A case series: The first One‐Centre experience with TDM
title_full_unstemmed Piperacillin/Tazobactam in critically ill morbidly obese patients: A case series: The first One‐Centre experience with TDM
title_short Piperacillin/Tazobactam in critically ill morbidly obese patients: A case series: The first One‐Centre experience with TDM
title_sort piperacillin tazobactam in critically ill morbidly obese patients a case series the first one centre experience with tdm
topic critical illness
morbid obesity
piperacillin/tazobactam (PIP/TAZO)
therapeutic drug monitoring (TDM)
url https://doi.org/10.1002/ccr3.7032
work_keys_str_mv AT mmieresova piperacillintazobactamincriticallyillmorbidlyobesepatientsacaseseriesthefirstonecentreexperiencewithtdm
AT kbalazova piperacillintazobactamincriticallyillmorbidlyobesepatientsacaseseriesthefirstonecentreexperiencewithtdm
AT jkubele piperacillintazobactamincriticallyillmorbidlyobesepatientsacaseseriesthefirstonecentreexperiencewithtdm
AT dcerny piperacillintazobactamincriticallyillmorbidlyobesepatientsacaseseriesthefirstonecentreexperiencewithtdm
AT mhalacova piperacillintazobactamincriticallyillmorbidlyobesepatientsacaseseriesthefirstonecentreexperiencewithtdm